Drug Patents owned by Kowa Pharms
1. List of Seglentis drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9012440 | KOWA PHARMS | Co-crystals of tramadol and coxibs |
Apr, 2030
(7 years from now) | |
| US10238668 | KOWA PHARMS | Co-crystals of tramadol and coxibis |
Apr, 2030
(7 years from now) | |
| US8598152 | KOWA PHARMS | Co-crystals of tramadol and coxibs |
Apr, 2030
(7 years from now) | |
| US10245276 | KOWA PHARMS | Co-crystals of tramadol and coxibs |
Apr, 2030
(7 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11478488 | KOWA PHARMS | NA |
Apr, 2030
(7 years from now) | |
| US10548909 | KOWA PHARMS | Co-crystals of tramadol and coxibs |
Apr, 2030
(7 years from now) | |
| US8846744 | KOWA PHARMS | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
Jun, 2031
(8 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Product (NP) | Oct 15, 2024 |
Drugs and Companies using CELECOXIB; TRAMADOL HYDROCHLORIDE ingredient
Market Authorisation Date: 15 October, 2021
Treatment: A method for treatment of pain in adults using tramadol hydrochloride and celecoxib
Dosage: TABLET;ORAL
SEGLENTIS family patents
12
United States
11
European Union
5
China
3
Israel
3
South Africa
3
Denmark
3
Mexico
3
Australia
3
Slovenia
3
Russia
3
Brazil
3
Croatia
3
Portugal
3
Cyprus
3
Spain
3
Korea, Republic of
3
Poland
3
Japan
3
Canada
3
New Zealand
2
Lithuania
2
Hungary
2
Argentina
2
Colombia
2
Singapore
2
Malaysia
2
San Marino
2
Taiwan, Province of China
2
Ecuador
2
Ukraine
2
Tunisia
1
Hong Kong
1
Morocco
1
RS
1
India
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic